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Abstract 
Fatty acyl esters of the yeast specifc sterol, ergosterol, are exclusively stored in lipid particles. Under conditions of sterol deficiency, 
e.g., in the presence of terbinafine, an inhibitor of fungal squalene poxidase, steryl esters are hydrolyzed, and sterols are set free for 
membrane formation. Lipid particles do not contain steryl-ester hydrolase activity themselves; the highest specific activity of this enzyme 
is found in the plasma membrane. Therefore, steryl esters have to be exported from lipid particles to their site of hydrolytic leavage. This 
process of translocation a d :metabolic conversion was studied in vivo. Addition of nocodazole to terbinafine-treated c lls did not disturb 
the mobilization of steryl esters, indicating that this process is not mediated by microtubuli-dependent v sicle flux. Under the influence of 
inhibitors of cellular energy production (azide and fluoride) and protein biosynthesis (cycloheximide) mobilization of steryl esters came to 
an halt. These results upport the view that ongoing membrane proliferation may be a driving force for the release of sterols from steryl 
esters of lipid particles. 
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1. Introduction 
Sterols are integral components of eukaryotic mem- 
branes. In yeast cells similar to higher eukaryotes the 
plasma membrane exhibits the highest sterol to protein and 
sterol to phospholipid ratio of all subcellular membranes 
[1,2]. The site of sterol synthesis has been reported to be 
the microsomal fraction [3] with specific contributions of 
the so-called lipid particles [2,4]. In the endoplasmic retic- 
ulum sterols can be esteriified with long-chain fatty acids, 
and steryl esters formed are stored in lipid particles to- 
gether with triacylglycerols [1,2,4,5]. Depending on the 
growth stage steryl estem are metabolically interconvert- 
ible with free sterols [6:,7]. The enzyme catalyzing the 
hydrolytic leavage of steryl esters, steryl-ester hydrolase, 
was detected at highest specific activity in the plasma 
membrane and protein secretory vesicles [2]. The latter 
location was found in temperature-sensitive yeast secretory 
mutants, which are blocked at a late stage of the protein 
secretory pathway. In these mutants proteins of the plasma 
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membrane, among them steryl-ester hydrolase, accumulate 
in secretory vesicles. 
The spatial separation of enzymes involved in the syn- 
thesis of sterols and steryl esters, and in the hydrolytic 
cleavage of the latter components necessitates several steps 
of intracellular sterol transport. Mechanisms proposed for 
sterol translocation are monomer transport with or without 
the aid of sterol carder proteins, or vesicles flow with or 
without an involvement of the protein secretory machinery 
(for reviews see Refs. [8,9]). While there is little proof for 
a participation of sterol carrier proteins in the intracellular 
movement of sterols in vivo, increasing evidence points to 
vesicle flow as a possible mechanism. It is an open 
question whether protein secretory vesicles or other types 
of intracellular vesicles govern this process. Enrichment of 
the yeast specific sterol, ergosterol, in protein secretory 
vesicles isolated from the temperature-sensitive yeast se- 
cretory mutant Saccharomyces cerevisiae secl [2] favors 
the view of the participation of the protein secretory 
machinery in sterol transport of yeast. On the other hand, 
sterol transport o the plasma membrane of mammalian 
cells was found to be unaffected by monensin and brefeldin 
A, drugs which are known to inhibit the secretion of 
proteins [10,11]. 
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Lipid particles of the yeast known as storage granula for 
triacylglycerols and steryl esters seem to be involved in 
sterol metabolism and transport. Recent observations in 
our laboratory demonstrated that at least one enzyme 
involved in sterol biosynthesis, terol A-24 methyltrans- 
ferase, is a component of lipid particles [4]. Sterols are 
obviously synthesized in a concerted action of enzymes 
located on the surface of the endoplasmic reticulum and 
lipid particles. Nothing is known about he cellular mecha- 
nism(s) leading to the deposition of steryl esters in lipid 
particles, nor about their export from this compartment 
during the mobilization of this sterol source. In order to 
characterize the latter process we designed an assay in 
vivo using terbinafine, an inhibitor of squalene poxidase 
[12]. Terbinafine causes sterol deficiency, which in turn 
leads to a mobilization of steryl esters from lipid particles. 
Cellular requirements for this process were tested using 
specific inhibitors of energy production, protein biosyn- 
thesis, and cytoskeleton i tegrity. 
2. Materials and methods 
2.1. Yeast strains, culture conditions and organelle prepa- 
rations 
The wild-type yeast strain Saccharomyces cerevisiae 
X2180-1A (a, SUC2, mal, gal2, CUP1) was cultivated in 
500 ml or 2 1 Erlenmeyer flasks at 30°C in a rotary shaker 
with vigorous aeration. For the preparation of lipid parti- 
cles and plasma membrane cells were pregrown in rich 
medium (YPD; 3% glucose, 1% yeast extract and 2% 
peptone) overnight to the exponential growth phase. Then 
cells were transferred to fresh sterol-free medium [13] 
buffered with citrate at pH 6.0. Terbinafine dissolved in 
ethanol was added at a final concentration of 30 /xg/ml, 
and cells were grown for 4 h at 30°C. Control cells were 
incubated for the same period in the presence of the 
corresponding amount of ethanol, but without terbinafine. 
Lipid particles [4], plasma membrane [14], vacuoles [4], 
and microsomes [1] were prepared by published proce- 
dures. Isolated fractions were characterized by SDS-PAGE 
and Western blotting (see below), and exhibited the same 
purity as described previously [1,2,4]. 
2.2. Steryl ester mobilization assay in vivo 
At time-points indicated aliquots of the culture (15 ml) 
were withdrawn, and cells were harvested by centrifuga- 
tion on a table top centrifuge. After shock-freezing in 
liquid nitrogen 5 ml chloroform/methanol (2:1; v /v )  were 
added, and cells were disintegrated by vigorous haking in 
the presence of 1 ml glass beads (diameter 0.3-0.4 mm) 
for 10 min at 4°C on an EVAPO-MIX (Buchler Instru- 
ments, Fort Lee, N J, USA). Cellular lipids were extracted 
as described by Folch et al. [15]. MgC12 (1 ml; 0.034%) 
was added, and samples were shaken for another 30 min at 
4°C. After centrifugation for 5 min on a table top cen- 
trifuge the aqueous phase was removed, and the organic 
phase was washed once with 1 ml methanol/water/chlo- 
roform (48:47:3; per vol.). Again the aqueous phase was 
removed, and the organic phase was saved. The sediment 
of glass beads formed during the previous steps was 
reextracted once with chloroform/methanol (2:1; v/v).  
Organic phases were combined, taken to dryness, and 
lipids were dissolved in 500 /zl chloroform/methanol 
(2:1; v/v).  
When yeast cells were treated with nocodazole (Sigma), 
the drug was dissolved in DMSO and added to the culture 
medium at a concentration f 15 gg /ml  2.5 h prior to the 
shift to sterol-free medium. Nocodazole-treated cells were 
arrested as large budded cells as described in the literature 
[16]. Sterol-free media contained either nocodazole (15 
/zg/ml), nocodazole plus terbinafine (same concentration 
as described above), or equivalents of DMSO and/or 
ethanol (solvents) as a control. Samples were withdrawn, 
and lipids were extracted as described above. 
In order to test the effect of energy depletion in combi- 
nation with the inhibition of sterol biosynthesis by 
terbinafine, wild-type yeast cells pregrown in rich medium 
(YPD) for 16 h were transferred tosterol-free medium, and 
cultures were divided into three portions. One culture was 
further incubated in the presence of terbinafine (30 
/xg/ml), the others in the absence of the inhibitor of sterol 
biosynthesis. After 30 min azide and fluoride (5 mM final 
concentration, each) were added to terbinafine-treated c lls 
and to one of the untreated cultures. The third culture, 
which served as a control, was devoid of any inhibitor. 
A similar protocol was used for the incubation of cells 
with cycloheximide in combination with terbinafine. One 
culture contained terbinafine (30 /zg/ml) and cyclohex- 
imide (5 /zg/ml), the second cycloheximide (5 /zg/ml), 
and the third no inhibitors at all. 
Yeast cells were pregrown in YPD medium for 16 h 
and transferred to sterol-free medium as described above. 
The culture was divided into two portions, and one half 
was treated with terbinafine (added as ethanolic solution) 
at a final concentration of 30 ~g/ml ,  the other half 
remained untreated as a control, but received the same 
volume of ethanol. Growth of yeast cells was determined 
by measuring the optical density with a Hitachi Ul l00 
UV/VIS Spectrophotometer at a wavelength of 600 nm. 
2.3. Labelling of the cellular lipids with [14C]acetate in 
the presence or absence of terbinafine 
Wild-type yeast cells were grown overnight in YPD 
medium and transferred to fresh sterol-free medium. The 
culture was divided into two portions (100 ml; OD 2 each), 
and terbinafine (final concentration 30 /zg/ml) was added 
to one of them. Then cells were labeled in the presence of 
[14C]acetate (12.5 /xCi; 3.7/zmol). Aliquots of the cultures 
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were withdrawn at time-points indicated, and cells were 
harvested by centrifugation. Cellular lipids were extracted 
with chioroform/methanol (2:1; v/v)  by the method of 
Folch et al. [15] after shock-freezing of cells as described 
above. 
2.4. Lipid analyses 
Neutral ipids were separated by thin-layer chromatog- 
raphy using silica gel 60, plates (Merck, Darmstadt, Ger- 
many). A two-step development system was employed. 
Solvent I contained light petroleum/diethyl ether (1:1, 
v/v). The chromatogranl was developed till the solvent 
front reached one third of the height on the thin-layer 
plate. After drying the plate carefully, solvent II consisting 
of light petroleum/diethyl ether (98:2; v/v)  was used for 
development in the same direction to the top of the thin- 
layer plate. This chromatographic system allows the sepa- 
ration of free sterols, terbinafine, steryl esters, squalene 
and triacylglycerols. ConLcentrations of ergosterol and er- 
gosteryl ester were detemfined after chromatographic sepa- 
ration by direct densitometry on thin-layer plates at 275 
nm using a Shimadzu C',S 930 thin-layer chromatography 
scanner with ergosterol a,; a standard. Squalene was visual- 
ized after separation on thin-layer plates by dipping the 
plates into conc. H2SO4/water/methanol (1:1:18; by vol.) 
and heating at 120°C for 15 min. Densitometric s anning 
was carried out at 465 nm using commercially available 
squalene as a standard. Triacylglycerols were visualized by 
dipping thin-layer plates into a solution containing 0.4 g 
MnC12, 60 ml water, 60 ml methanol and 4 ml H2SO 4, 
and heating at 120°C for 15 min. Quantitation of triacyl2 
glycerols was carried out by densitometric s anning at 400 
nm with triolein as a standard. 
Labeled neutral ipids were separated on silica gel 60 
thin-layer chromatograpky plates employing the two-step 
development system described above. In order to separate 
diacylglycerols from free sterols a developing solvent con- 
taining toluene/diethyl ether/ethyl acetate/25% ammonia 
(80:10:10:0.2; by vol.) was used. Lipids were visualized on 
thin-layer plates after exposure to iodine vapor, scraped 
off, and subjected to liquid scintillation counting using 
I~C Safety Cocktail (Packard) with 5% water. 
Phospholipids were quantitated as described by 
Broekhuyse [17]. 
2.5. Protein quantitation, SDS-polyacrylamide gel elec- 
trophoresis, and Western blot analysis 
Proteins were quantitated by the method of Lowry et al. 
[18] using bovine serura albumin as a standard. Lipid 
particles (20 /xg protein)had to be delipidated by extrac- 
tion with diethyl ether (2 × 0.5 ml) prior to the colori- 
metric assay. Proteins were routinely precipitated with 
10% trichloroacetic a id and solubilized in 0.1% SDS-0.1 
M NaOH for quantitation. 
For SDS-polyacrylamide g l electrophoresis of their 
proteins, lipid particles were delipidated with diethyl ether 
as described above. Protein (20/zg) was precipitated with 
10% trichloroacetic acid, washed with distilled water at 
0°C, and dissolved in dissociation buffer containing 6% 
SDS. Protein bands on the gel were visualized with 
Coomassie Brilliant Blue R. 
Immunological characterization f subcellular fractions 
was carried out by standard techniques [19] after separat- 
ing proteins on 12.5% SDS polyacrylamide g ls and trans- 
ferring to nitrocellulose filters (Hybond~-C, Amersham). 
Proteins were detected by ELISA using rabbit antibodies 
against he respective antigens, and peroxidase-conjugated 
goat-anti-rabbit secondary antibodies. Antisera against 
yeast plasma membrane ATPase and yeast carboxypepti- 
dase Y were gifts of R. Serrano, Valencia, Spain, and D. 
Wolf, Stuttgart, Germany, respectively. 
3. Results 
Exclusive storage of steryl esters in lipid particles on 
one hand, and localization of steryl-ester hydrolase at 
highest specific activity in the plasma membrane and in 
secretory vesicles [2] of the yeast, Saccharomyces cere- 
visiae, on the other hand, raised the question as to path- 
way(s) and mechanism(s) of the migration of these lipids 
to the cell periphery. We designed an assay to study export 
of steryl esters from lipid particles and hydrolysis in vivo, 
and made use of terbinafine, an inhibitor of fungal squa- 
lene epoxidase, to cause sterol deficiency. Synthesis of 
sterols de novo and, as a consequence, of steryl esters was 
inhibited, when yeast cells were incubated in sterol-free 
medium at pH 6.0 with 30 /zg/ml terbinafine [12]. Treat- 
ment of cells with terbinafine resulted in a dramatic reduc- 
tion of the rate of incorporation of [aac]acetate into sterols 
and steryl esters (Fig. 1C) to less than 5% of the control 
(Fig. 1B), whereas an accumulation of the label in squa- 
lene was observed (Fig. 1C). These data demonstrate, that 
under conditions chosen for this in vivo assay yeast cells 
could not synthesize sterols any more, although cellular 
growth continued for several hours at a reduced rate (Fig. 
1A). Inhibition of de novo sterol synthesis was a pre- 
requisite for measuring the mobilization of pre-existing 
cellular pools of steryl esters. Enzyme assays in vitro (data 
not shown) demonstrated that terbinafine did not influence 
steryl-ester hydrolase. 
When wild-type yeast cells were incubated in the pres- 
ence of 30 /xg/ml terbinafine, the cellular level of er- 
gosteryl esters dropped to zero within 2 h (Fig. 2C), 
indicating that the sterol moiety of ergosteryl esters was 
set free under conditions of sterol depletion. The cellular 
amount of free ergosterol decreased to approx. 60% of the 
starting level within 4 h, and a dramatic accumulation of
squalene was observed due to the inhibitory effect of 
terbinafine on squalene poxidase. In control cells (Fig. 
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Fig. 1. Labelling of wild-type yeast cells (Saccharomyces cerevisiae 
X2180-1A) with [14C]acetate. Yeast cells were grown overnight in YPD- 
medium, transferred to sterol-free medium, and incubated in the presence 
(30 p,g/ml) or absence of terbinafine. Labelling conditions with 
[14C]acetate are described under Materials and methods. At time-points 
indicated aliquots of the culture were withdrawn, and lipids were ex- 
tracted and analyzed. (A) Growth curves of yeast cells grown in the 
presence (• )  or absence ([]) of terbinafine. (B) Distribution of 14C-label 
in ergosterol ([]), ergosteryl esters (• ) ,  and squalene (• )  of cells grown 
in the absence of terbinafine. (C) Distribution of 14C-label in ergosterol 
([]), ergosteryl esters (• ) ,  and squalene (• )  of cells grown in the 
presence of terbinafine. 
2B) concentrations of free ergosterol, ergosteryl esters and 
squalene remained fairly constant over the whole period of 
the experiment. The fact that cellular growth (Fig. 2A) was 
only slightly reduced when the concentration of steryl 
esters had dropped to zero demonstrates, that this lipid is 
not essential for yeast cells. In contrast a minimum level of 
free sterols (approx. 25% of normal) is absolutely required 
for yeast cell viability [20]. This level was not reached 
under conditions chosen for the experiment shown in Fig. 
2. 
Detailed analysis of subcellular fractions (Table 1) 
demonstrated that under conditions of sterol deficiency, 
i.e., in the presence of the inhibitor terbinafine, steryl 
esters of lipid particles were completely used up. The level 
of triacylglycerols in lipid particles, on the other hand, was 
only slightly decreased, which is consistent with the view 
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Fig. 2. Mobilization of steryl esters under conditions of sterol depletion. 
Cells were pregrown in YPD-medium overnight, ransferred to sterol-free 
medium, and incubated in the presence (30 /~g/ml) or absence of 
terbinafine. At time-points indicated cells were harvested, lipids were 
extracted and analyzed by optical scanning on thin-layer plates as out- 
lined in Materials and methods. (A) Growth curves of yeast cells grown 
in the presence (0 )  or absence ([]) of terbinafine. (B) Amount of 
ergosterol ([]), ergosteryl esters ( • ), and squalene (• )  per OD of cells 
grown in the absence of terbinafine. (C) Amount of ergosterol (•), 
ergosteryl esters (• ) ,  and squalene (• )  per OD of cells grown in the 
presence of terbinaf'me. 
that a selective mobilization of steryl esters, but not a 
'bulk mobilization' of lipid particles, occurred. Interest- 
ingly squalene, the metabolic intermediate accumulating in
Table 1 
Lipid composition of lipid particles and plasma membrane of wild-type 
yeast cells grown in the absence or presence of terbinafine 
Lipid composition (mg/mg protein) 
lipid particles plasma membrane 
- terbinafine + terbinafine - terbinafine + terbinafine 
Ergosterol 0.06 n.d. 0.13 0.09 
Ergosteryl esters 2.6 n.d. traces n.d. 
Squalene 1.1 4.5 traces traces 
Triacylglycerols 19.6 16.1 - - 
Phospholipids - - 0.251 0.255 
Yeast cells were grown for 4 h in the presence or absence of terbinafine 
as outlined in Materials and methods. Mean values of three independent 
experiments are shown, n.d., not detectable; - ,  not determined. 
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terbinafine-treated cells, was highly enriched in lipid parti- 
des. Synthesis of squalene has been reported to be a 
microsomal process (see Ref. [3]), and its translocation to 
lipid storage particles might be the consequence of the 
overproduction. The plasma membrane of terbinafine- 
treated yeast cells exhibited a lower concentration of free 
ergosterol than the plasma membrane of control cells. This 
decrease to 60% of the control reflected the overall situa- 
tion in whole cells (see F'ig. 2C). Neither steryl esters nor 
squalene were found at significant amounts in the plasma 
membrane of terbinafine-treated cells. 
Where does the hydrolysis of steryl esters occur in yeast 
cells treated with terbinafine? In untreated cells the highest 
specific activity of steryl-ester hydrolase (0.35 nmol /min 
per mg) was attributed to the plasma membrane; only 
minor activities were fottnd in other organelles (see Ref. 
[2]). Lipid particles are absolutely devoid of steryl-ester 
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Fig. 4. Energy dependence of the mobilization ofsteryl esters. Cells were 
pregrown on YPD-medinm and shifted to sterol-free medium. After 30 
min of incubation (indicated by the arrow) azide and fluoride (final 
concentration 5 mM each) were added. (A) Growth curves of yeast ceils 
grown in the presence ofazide and fuoride (•), of terbinafine, azide and 
fluoride (•),  or in the absence of all inhibitors ([]). (B) Amount of 
ergosterol ( [] ), ergosteryl esters (•), and squalene (• )  per OD of ceils 
incubated in the presence of azide and fluoride, but in the absence of 
terbinafine. (C) Amount of ergosterol ([]), ergosteryl esters (•), and 
squalene (11) per OD of cells grown in the presence of azide, fluoride 
and terbinafine. 
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Fig. 3. The microtubuli d srupling agent nocodazole does not inhibit he 
mobilization ofsteryl esters. Cells were pregrown on YPD-medinm. 2 5 h 
prior to the shift to sterol-free medium 15/.~g/ml nocodazole was added. 
The sterol-free medium contained the same concentration f nocodazole 
throughout the whole experime:at. (A) Growth curves of yeast cells grown 
in the presence ofnocodazole (•),  of terbinafine and nocodazole (•), or 
in the absence of both drug:~ ([]). (B) Amount of ergosterol ([]), 
ergosteryl esters (0), and squalene (• )  per OD of ceils grown in the 
presence ofnocodazole, but in the absence of terbinafine. (C) Amount of 
ergosterol ([]), ergosteryl esters (•), and squalene (• )  per OD of cells 
grown in the presence ofnocodazole and terbinafine. 
hydrolase activity. Similar results were obtained with sub- 
cellular fractions of terbinafine-treated cells. Again prepa- 
rations of the plasma membrane exhibited the highest 
specific activity of steryl-ester hydrolase (0.30 nmol /min 
per mg), and lipid particles completely lacked this enzyme 
activity. The fact that lipid particles are physically associ- 
ated with vacuoles in vivo as observed by microscopic 
inspection (E. Zinser, unpublished observation) led us to 
speculate that vacuoles, like lysosomes in mammalian cells 
(for a review see Ref. [21]), might be involved in hydro- 
lytic cleavage and mobilization of steryl esters. However, 
steryl-ester hydrolase could never be measured at a signifi- 
cant activity in highly purified preparations of yeast vac- 
uoles. 
The assay system in vivo described above allowed us to 
test cellular requirements for the acquisition of sterols 
from steryl esters, which is linked to the export of the 
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latter component from lipid particles. We first asked the 
question whether or not mobilization of steryl esters from 
lipid particles depends on the existence of an intact cyto- 
skeleton. We employed nocodazole (15/xg/ml) to disrupt 
microtubuli of yeast cells during a preincubation of 2.5 h. 
Cellular growth of nocodazole-treated yeast was largely 
inhibited (Fig. 3A). During continued incubation with 
nocodazole an increase in the amounts of ergosteryl esters, 
free ergosterol and squalene was observed (Fig. 3B). The 
reason for this effect seems to be the ongoing synthesis of 
sterols while the growth rate was strongly reduced. When 
terbinafine was added to cells pretreated with nocodazole 
(Fig. 3C) the concentration f ergosteryl esters reached the 
zero level after 4 h. The slower rate of mobilization as 
compared to the control without nocodazole (see Fig. 2C) 
was probably due to the reduced growth rate. 
In order to test the energy requirement of the transport- 
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Fig. 5. Mobilization of steryl esters in yeast cells treated with cyclohex- 
imide. Cells were pregrown on YPD-medium. and shifted to sterol-free 
medium. After 30 rain of incubation (indicated by the arrow) eyclohex- 
imide (final concentration 5 /zg/ml) was added. (A) Growth curves of 
yeast cells grown in the presence of cycloheximide ( . ) ,  of terbinafine 
and cycloheximide (• ) ,  or in the absence of all inhibitors (n) .  (B) 
Amount of ergosterol ([]), ergosteryl esters (• ) ,  and squalene (• )  per 
OD of cells incubated in the presence of cycloheximide, but in the 
absence of terbinafine. (C) Amount of ergosterol ([]), ergosteryl esters 
(O), and squalene (• )  per OD of cells grown in the presence of 
cycloheximide and terbinafine. 
linked mobilization of ergosteryl ester from lipid particles, 
yeast cells treated with azide and fluoride were incubated 
with or without terbinafine (Fig. 4). When azide and 
fluoride were added to the culture medium, cells stopped 
growing after 30 min (Fig. 4A). A slight increase in the 
concentration f steryl esters and a minor decrease of free 
sterols was observed (Fig. 4B). Internal pools of activated 
fatty acids might be utilized for steryl ester biosynthesis at
this stage. Then the concentration of all lipids remained 
constant, indicating that neither synthesis of sterols and 
steryl esters, nor interconversion f these two lipid species 
occurred. Levels of lipids were also unchanged when 
terbinafine was present in the culture medium in addition 
to azide and fluoride (Fig. 4C). 
The view that a linkage between mobilization of steryl 
esters from lipid particles and membrane proliferation 
exists was supported by an experiment using cyclohex- 
imide (5/~g/ml) as an inhibitor in addition to terbinafine. 
Cycloheximide, an inhibitor of protein synthesis n eukary- 
otes, was added to the culture medium after cells had 
grown for 30 min in the presence (Fig. 5C) or absence 
(Fig. 5B) of terbinafine. Cycloheximide dramatically re- 
duced the growth rate of yeast cells (Fig. 5A). In the 
absence of terbinafine cycloheximide caused an increase of 
the concentration f steryl esters and squalene, but not of 
free sterols (Fig. 5B). When cycloheximide was used in 
combination with terbinafine, the cellular content of steryl 
esters continued to decrease slightly for 30 min after the 
addition of cycloheximide, but then remained constant 
(Fig. 5C). 
4. Discussion 
In the present paper we propose the involvement of 
lipid particles, the site of storage of sterols esterified with 
long-chain fatty acids, in the intracellular transport of 
sterols, based on synthesis and hydrolysis of steryl esters. 
In the yeast, Saccharomyces revisiae, steryl esters and 
free sterols are interconvertible d pending on the growth 
phase. The concentration of steryl esters is high in the 
stationary phase, but relatively low in the lag and exponen- 
tial growth phase [6,7]. Under sterol depletion caused by 
incubation of yeast cells with terbinafine, steryl esters were 
mobilized very rapidly even in the exponential growth 
phase (see Fig. 2). The reason for this mobilization is 
obviously a demand of free sterols for membrane forma- 
tion, mainly of the plasma membrane. Lipid particles 
isolated from cells 4 h after the addition of terbinafine 
were completely devoid of steryl esters, whereas the plasma 
membrane still contained sterols at a level sufficient for 
cell viability (see Table 1). Levels of free sterols and steryl 
esters in other organelles, e.g., vacuoles or microsomes 
were not affected by the treatment with terbinafine. 
Experiments with deenergized yeast cells (see Fig. 4) 
suggest hat either transport of steryl esters from lipid 
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particles to their site of hydrolysis (plasma membrane) is
energy dependent, or that the requirement of free sterols 
coupled to membrane proliferation, especially to that of the 
plasma membrane, is a drilving force for steryl ester mobi- 
lization. When yeast cell,; were poisoned with cyclohex- 
imide membrane proliferation stopped, but cellular energy 
levels were maintained. Under these conditions hydrolysis 
of steryl esters came to an halt (see Fig. 5) suggesting that 
transport of steryl esters to the site of hydrolysis and 
ongoing membrane proliferation may be linked processes. 
This view is supported by the finding that yeast cells 
accumulate steryl esters in lipid particles in the stationary 
growth phase, because there is practically no membrane 
proliferation at this stage. As a consequence the pathway 
of steryl ester mobilization from lipid particles might be 
inactivated, and sterols still produced are stored in the 
form of steryl esters in lipid particles. Further, although 
indirect support o this hypothesis comes from the observa- 
tion, that all attempts failed to reconstitute migration of 
steryl esters from lipid particles to the plasma membrane 
and subsequent hydrolysi:s in vitro, i.e., under conditions 
when cell proliferation does not occur (E. Zinser, unpub- 
lished results). Plasma membrane proliferation as a driving 
force of sterol acquisitic,n was also suggested by Bill- 
heimer and Reinhart [8] for mammalian cells. 
Export of steryl esters from lipid particles does not 
depend on the existence of intact microtubuli as demon- 
strated by experiments using the microtubuli disrupting 
agent nocodazole (see FIE;. 3). Energy driven vesicle flux, 
e.g., flow of protein secretory vesicles [22] as a mechanism 
of steryl ester transport to the cell periphery is therefore 
unlikely. At present we can only speculate about the true 
mechanism(s) of this translocation process. Flux of special- 
ized vesicles described previously for the transport of 
phospholipids to the plasma membrane of Dictyostelium 
discoideum, which are different from protein secretory 
vesicles [23], could be involved. Alternatively lipid parti- 
cles might migrate directly to the site of steryl ester 
hydrolysis. During membrane contact, e.g., with the plasma 
membrane, the subcellul~.r location with the highest spe- 
cific activity of steryl-es~Ier hydrolase and the maximum 
requirement of free sterols, an intermediate complex might 
be formed, which would allow release and subsequent 
hydrolysis of steryl esters. A similar mechanism was pro- 
posed by Reinhart [9] for the translocation of cholesterol 
esters from lipoproteins to the plasma membrane of mam- 
malian cells. Interaction of yeast lipid particles with other 
organelles, e.g., the plasma membrane, which harbors 
steryl-ester hydrolase activity, cannot be an unspecific 
event, and might be triggered by organellar factors. Sur- 
face proteins of lipid particles [4] might mediate this 
process. Experiments are on the way to characterize lipid 
particle proteins in order to obtain more insight into the 
molecular basis of interorganelle translocation of sterols. 
More than 50% of sterols esterified with fatty acids and 
present in lipid particles are different from ergosterol, 
namely zymosterol, episterol, fecosterol and other interme- 
diates of sterol biosynthesis [2]. Free sterols of the plasma 
membrane, on the other hand, comprise 95% ergosterol, 
also in cells treated with terbinaf'me. Fatty acyl esters of 
sterol intermediates are obviously not transported directly 
to the plasma membrane, hydrolyzed and inserted without 
prior metabolic onversion. Since conversion of precursor 
sterols to ergosterol has never been shown to occur at the 
stage of steryl esters, hydrolytic cleavage of the latter 
sterol derivatives should precede the formation of the final 
product, ergosterol. In that case, conversion of precursors 
to ergosterol should either be catalyzed by enzymes lo- 
cated on the surface of lipid particles, or lipid particles 
would have to interact with internal membranes which 
harbor enzymes required for the respective metabolic steps. 
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